HT29 Cells
HT29 cells are a human colorectal cancer cell line derived from the primary tumor of a colon cancer patient in 1979. They have been widely used to study the processes of colorectal cancer and its treatments, due to their high sensitivity to radiation and chemotherapy. In addition, their relatively simple genome has enabled identification of novel biomarkers for colorectal cancer, which have aided in the development of more personalized drug therapies that target specific biomarkers. HT29 cells are also useful for studying the cellular and molecular mechanisms of drug-resistance in colorectal cancer, furthering our understanding of this challenging disease and helping to improve patient outcomes.
← Journal of Colon And Rectal Cancer